COMMUNIQUÉS West-GlobeNewswire

InspireMD to Announce Second Quarter 2026 Financial Results
10/08/2026
MIAMI, Aug. 10, 2026 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR) (“InspireMD” or the “Company”), developer of the CGuard™ Prime carotid stent system for the prevention of stroke, today announced it will issue its [...]
IN8bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
10/08/2026
NEW YORK, Aug. 10, 2026 (GLOBE NEWSWIRE) -- IN8bio, Inc. (the “Company”) (Nasdaq: INAB), a clinical-stage biopharmaceutical company developing innovative gamma-delta (γδ) T cell therapies and T cell engagers for cancer [...]
Septerna Highlights Business Progress and Reports Second Quarter 2026 Financial Results
10/08/2026
Phase 1 Clinical Trial Ongoing for SEP-479, an Oral Small Molecule PTH1R Agonist SEP-479 Observed Clinical Pharmacokinetic Profile Supports Once-Daily Dosing; SAD / MAD Data Expected in Q1 2027 Cash Position of $516.5 [...]
BridgeBio Reports Second Quarter 2026 Financial Results and Corporate Updates
10/08/2026
- $243.7 million in total second quarter revenues, primarily comprised of $222.4 million of U.S. Attruby® net product revenue, with growth led by the treatment-naïve segment as physicians increasingly start and keep [...]
C4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
10/08/2026
WATERTOWN, Mass., Aug. 10, 2026 (GLOBE NEWSWIRE) -- C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation science, today announced [...]
Alpha Tau Announces Second Quarter 2026 Financial Results and Provides Corporate Update
10/08/2026
- Groundbreaking interim results from the U.S. recurrent glioblastoma REGAIN trial demonstrated 100% local disease control and a 67% complete response rate, followed by FDA clearance to complete trial enrollment and to [...]
Mesa Labs Announces First Quarter Results
10/08/2026
LAKEWOOD, Colo., Aug. 10, 2026 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (“Mesa” or the “Company”), a global leader in the design and manufacture of life science tools and critical quality control [...]
Olema Oncology Reports Second Quarter 2026 Financial and Operating Results
10/08/2026
Completed enrollment in the pivotal Phase 3 OPERA-01 trial; top-line data are now expected in the first quarter of 2027 Presented initial Phase 1 clinical data for OP-3136 at the 2026 ASCO Annual Meeting Announced a [...]
HRC Technology Solutions LLC Achieves SOC 1 Type 2 and SOC 2 Type 2 Compliance, Reinforcing Secure, AI-Driven Revenue Cycle Management
10/08/2026
SOUTHLAKE, Texas, Aug. 10, 2026 (GLOBE NEWSWIRE) -- HRC Technology Solutions LLC today announced it has achieved SOC 1 Type 2 and SOC 2 Type 2 compliance, independently assessed by ControlCase as its Qualified Security [...]
MAPS Responds to Report of Progress for MDMA-assisted therapy for PTSD with FDA
10/08/2026
The reported resubmission of the New Drug Application will initiate a new evaluation of the treatment’s safety and efficacy for potential FDA approval Recently updated FDA guidance, Psychedelic Drugs: Considerations for [...]
Women's Health Collective Canada and GreenShield Launch Partnership to Advance Midlife Women's Health Research and Support
10/08/2026
National partnership will help generate critical evidence and improve awareness, education, and support for women navigating the menopause transition and beyond in Canada TORONTO, Aug. 10, 2026 (GLOBE NEWSWIRE) -- Women [...]
L’Association canadienne pour l’équité en santé des femmes et GreenShield lancent un partenariat en faveur de la recherche et du soutien dans le domaine de la santé des femmes dans la cinquantaine
10/08/2026
Ce partenariat national aidera à produire des données probantes et à améliorer les ressources de sensibilisation, d’éducation et de soutien pour les femmes vivant la transition vers la ménopause au Canada TORONTO, 10 [...]
Compass Health to purchase Friday Harbor facility from San Juan County, supporting behavioral health care in the islands long-term
10/08/2026
State funding and a decades-long county partnership secure the building's future FRIDAY HARBOR, Wash., Aug. 10, 2026 (GLOBE NEWSWIRE) -- Compass Health is purchasing its Friday Harbor facility located at 520 Spring [...]
IPSEN - Buy-back programme - Art 5 of MAR - Week 32 - 2026
10/08/2026
Aggregated presentation by day and by market Weekly report on share repurchases from 04th August to 05th August 2026 Name of the Issuer Identify code of the Issuer Transaction day Identify code of the financial [...]
IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - Semaine 32 - 2026
10/08/2026
Présentation agrégée par jour et par marché Déclaration des transactions sur actions propres réalisées du 4 août au 5 août 2026 Nom de l'émetteur Code identifiant de l'émetteur (code LEI) Jour de la transaction Code [...]
Helus Pharma to Participate at the Canaccord Genuity 46th Annual Growth Conference in Boston
10/08/2026
CEO Michael Halstead to participate in a fireside chat on Wednesday, August 12 at 12:00 p.m. EDT NEW YORK and TORONTO, Aug. 10, 2026 (GLOBE NEWSWIRE) -- Helus Pharma™ (Nasdaq: HELP) (Cboe CA: HELP) (the “Company” or “ [...]
Metabio Advances Global Preventive Healthcare with Integrated AI-Powered Bioresonance Ecosystem
10/08/2026
HONG KONG, Aug. 10, 2026 (GLOBE NEWSWIRE) -- As global healthcare priorities increasingly shift from reactive treatment to proactive wellness management, health technology enterprise Metabio today announced the [...]
NTG Nordic Transport Group publishes interim report for H1 2026
10/08/2026
Company announcement no. 29 – 26 10 August 2026 NTG Nordic Transport Group publishes interim report for H1 2026 The interim report for H1 2026 is enclosed. In connection with publication of the results for H1 2026, a [...]
Zealand Pharma - Transactions related to share buy-back program (week 32, 2026)
10/08/2026
Company announcement No. 37 / 2026 Zealand Pharma - Transactions related to share buy-back program (week 32, 2026) Copenhagen, Denmark, August 10, 2026 – Zealand Pharma A/S ("the Company" or “Zealand Pharma”) (Nasdaq: [...]

Pages